|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 14151089.1 (espacenet) (Federated) (European Patent Register), 20081010 | | Patent/reg. no. and date | DK/EP 2722046, 20161221 | | Publication date | 20140423 | | Priority no. and date | US 979643 P, 20071012 | | EP pub. no. and date |
EP 2722046 20140423 | | Effective date | | | Applicant/owner | AbbVie Ireland Unlimited Company, 70 Sir John Rogerson's Quay
Dublin 2, IE | | Applicant ref. no. | P22383DKEP | | Inventor | KOLACZKOWSKI, Lawrence, 5822 Constitution Avenue
Gurnee, IL 60031, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61P 35/00 (2006.01) , C07D 403/04 (2006.01) | | Title | 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazol-4-carboxamid-krystalform 1 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
